Source: The Lakeside, OR weather data displayed above is derived from the NOAA (National Oceanic and Atmospheric). Air quality and pollution data is derived from the EPA (United States Environmental Protection Agency).
DUBLIN, June 15, 2016 /PRNewswire/ -- Allergan plc (NYSE: AGN) announced today that the 510(k) Premarket Notification Application for the XEN Glaucoma Treatment System (consisting of the XEN45 Gel Stent and the XEN Injector) has been accepted for filing by the U.S. Food and Drug Administration (FDA).
Apparently the FDA approved stents that elute statin drugs, so if a patient has side effects from the statins within the stent, they are basically out of luck, or need to have the stents replaced. These stents are now causing major adverse cardiac events 2-5 years post-placement.